Risk of hepatitis A virus infection in persons with hemophilia receiving plasma-derived products

Transfus Med Rev. 2000 Jan;14(1):64-73. doi: 10.1016/s0887-7963(00)80116-9.
No abstract available

Publication types

  • Review

MeSH terms

  • Blood Component Transfusion / adverse effects*
  • Blood Component Transfusion / standards
  • Consumer Product Safety
  • Hemophilia A / complications
  • Hemophilia A / therapy
  • Hemophilia A / virology*
  • Hepatitis A / blood
  • Hepatitis A / etiology*
  • Humans